Astellas cuts 600 positions in Japan as new CEO makes his mark

Joining a host of other drug companies announcing slim-down efforts in recent months, Astellas is shedding 600 positions in Japan in R&D and sales and marketing.
Read the full story: FiercePharma: Pharma